Contact Me for a Free Consultation [email protected]

Case Results

New Uses for Known Compounds

As outside counsel, helped Dynogen Pharmaceuticals, a neuroscience-based pharmaceutical company, build an international patent portfolio around new formulations and indications for known compounds to treat genitourinary and gastrointestinal disorders. Dynogen raised $63M in funding and signed a merger agreement with Apex Bioventures in which Dynogen shareholders were to receive $98 million in Apex Bioventures stock. The deal would have also provided the combined entity with up to $65M to finance Dynogen's late-stage clinical trials and product development activities. Unfortunately, Dynogen was a victim of the 2008 financial crisis and the deal ultimately fell through. Exemplary patent applications are provided below.

WO2004058168.pdf
WO2004058168 - Methods of Treating Non-Painful Bladder Disorders Using Alpha-2-Delta Subunit Calcium Channel Modulators (produced 16 national applications and a granted European patent).
WO2004084879.pdf
WO2004084879 - Methods for Treating Lower Urinary Tract Disorders Using Smooth Muscle Modulators and Alpha-2-Delta Subunit Calcium Channel Modulators (produced over 20 national applications, a granted European patent, and US notice of allowance).

Contact Me

EIPL_20New_20Logo_2010-24-3.jpg

I'm happy to schedule a free 15-minute consultation to discuss your IP needs.

Whether you're a tinkerer who's come up with a new gadget or the CEO of a start-up that doesn't yet have the budget for a full-time in-house IP attorney, schedule a call.

The content of this website is for informational purposes only. The information provided herein is not intended as legal advice or as a legal opinion, and does not create an attorney-client relationship with website visitors. Readers of the website or of any linked websites should not act upon any information in them without first obtaining professional counsel on the subject matter. Every case or matter is unique with its own facts and applicable law, and success in prior cases or matters does not guarantee a similar outcome in another case or matter.

Menu